Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy

PURPOSE: To determine the efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% preserved with polyquaternium-1 in patients with insufficient response to bimatoprost 0.03%/timolol 0.5% preserved with benzalkonium chloride. PATIENTS AND METHODS: In this open-label nonrandomized stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Schnober, Dietmar, Hubatsch, Douglas A, Scherzer, Maria-Luise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428365/
https://www.ncbi.nlm.nih.gov/pubmed/26005326
http://dx.doi.org/10.2147/OPTH.S80880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428365/
https://www.ncbi.nlm.nih.gov/pubmed/26005326
http://dx.doi.org/10.2147/OPTH.S80880

Ejemplares similares